Richard Gregory
Directeur/Bestuurslid bij CANBRIDGE PHARMACEUTICALS INC.
Actieve functies van Richard Gregory
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CANBRIDGE PHARMACEUTICALS INC. | Directeur/Bestuurslid | 21-04-2020 | - |
Independent Dir/Board Member | 21-04-2020 | - |
Loopbaan van Richard Gregory
Eerdere bekende functies van Richard Gregory
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
PROMIS NEUROSCIENCES, INC. | Directeur/Bestuurslid | 18-10-2016 | 27-04-2023 |
Independent Dir/Board Member | 18-10-2016 | 27-04-2023 | |
IMMUNOGEN, INC. | Hoofd Techniek/Wetenschap/O&O | 05-01-2015 | 30-08-2019 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Hoofd Techniek/Wetenschap/O&O | 01-01-2003 | 01-01-2014 |
Canbridge Pharmaceuticals, Inc. (United States)
Canbridge Pharmaceuticals, Inc. (United States) BiotechnologyHealth Technology Part of CANbridge Pharmaceuticals Inc., Canbridge Pharmaceuticals is a rare disease-focused biopharmaceutical company based in Cambridge, MA. Canbridge Pharmaceuticals, Inc. (United States) was established in 2012 and is committed to researching, developing, and commercializing transformative therapies for rare diseases. | Directeur/Bestuurslid | 28-04-2020 | - |
Hoofd Techniek/Wetenschap/O&O | 28-04-2020 | - | |
Q32 BIO INC. | Directeur/Bestuurslid | 01-01-2015 | - |
Independent Dir/Board Member | 01-01-2015 | - |
Opleiding van Richard Gregory
University of Massachusetts | Doctorate Degree |
Virginia Polytechnic Institute & State University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 7 |
Canada | 2 |
China | 2 |
Operationeel
Director/Board Member | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Independent Dir/Board Member | 3 |
Sectoraal
Health Technology | 7 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
PROMIS NEUROSCIENCES, INC. | Health Technology |
CANBRIDGE PHARMACEUTICALS INC. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
ImmunoGen, Inc.
ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
Homology Medicines, Inc.
Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the translation of proprietary gene editing and gene therapy technology into novel treatments for patients with rare genetic diseases. The company was founded in March 2015 and is headquartered in Bedford, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Canbridge Pharmaceuticals, Inc. (United States)
Canbridge Pharmaceuticals, Inc. (United States) BiotechnologyHealth Technology Part of CANbridge Pharmaceuticals Inc., Canbridge Pharmaceuticals is a rare disease-focused biopharmaceutical company based in Cambridge, MA. Canbridge Pharmaceuticals, Inc. (United States) was established in 2012 and is committed to researching, developing, and commercializing transformative therapies for rare diseases. | Health Technology |
- Beurs
- Insiders
- Richard Gregory
- Ervaring